IMCR:NASDAQ, Immunocore Holdings plc

IMCR stock overview

Immunocore Holdings plc (IMCR:NASDAQ) closed at $26.41 on November 20, 2026, down 0.83% on the day. The stock trades 35.1% below its 52-week high of $40.72 and 3.1% above its 52-week low of $25.61. Over the past year, it lost 32.9%. Immunocore Holdings plc is part of the Health Care sector.

Key figures

Price
$26.41
Day change
-0.83%
Volume
546,182
Average volume
447,495
Market cap
1B+
52-week range
$25.61 – $40.72
50-day average
$30.49
200-day average
$31.49

Price action over the past year

In 252 trading sessions since November 20, 2025, IMCR closed higher on 116 days (46%). Its best day was October 20, 2026 (+9.25%) and its worst was April 21, 2026 (-6.17%). It never moved 10% or more in a single session.

Recent signals

IMCR news

About Immunocore Holdings plc

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Similar stocks

Find more stocks like IMCR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.